Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome - Wikidata - wikimedia - TriplyDB

Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome

Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome

http://www.wikidata.org/entity/Q34034971

about

Clinical features, comorbidity, and cognitive impairment in elderly bipolar patients Cardiometabolic Health in Bipolar Disorder Aging changes and medical complexity in late-life bipolar disorder: emerging research findings that may help advance care.PPAR-γ agonism as a modulator of mood: proof-of-concept for pioglitazone in bipolar depression.Factors affecting hospital stay in psychiatric patients: the role of active comorbidity.Comorbid medical illness in bipolar disorder The incidence and relative risk of stroke among patients with bipolar disorder: a seven-year follow-up study.The burden of obesity among adults with bipolar disorder in the United States Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: long-term changes in weight and metabolic profiles DNA methylation, insulin resistance and second-generation antipsychotics in bipolar disorder.Association of quetiapine with ischemic brain stem stroke: a case report and discussion.Metabolic syndrome and adverse clinical outcomes in patients with bipolar disorder.Patient perceptions of physical health and bipolar symptoms: The intersection of mental and physical health Lifestyle interventions targeting dietary habits and exercise in bipolar disorder: A systematic review.The Connection between Cardiac and Mental Disorder: Atrial Fibrillation in Patients with Psychiatric Disorder.Obesity and the three-year longitudinal course of bipolar disorder.Correlates of treatment response in depressed older adults with bipolar disorder Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder.General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial.Associations among obesity, acute weight gain, and response to treatment with olanzapine in adolescent schizophrenia.The effect of bariatric surgery on psychiatric course among patients with bipolar disorder.Dosing patterns and medication adherence in bipolar disorder patients treated with lurasidone: a US retrospective claims database analysis.Molecular Mechanisms of Bipolar Disorder: Progress Made and Future Challenges.Gene-specific DNA methylation may mediate atypical antipsychotic-induced insulin resistance.Medication burden in bipolar disorder: a chart review of patients at psychiatric hospital admission.Surgical treatment of morbid obesity among patients with bipolar disorder: a research agenda.The relationship between bipolar disorder and type 2 diabetes: more than just co-morbid disorders.Beyond the guidelines for bipolar disorder: practical issues in long-term treatment with lithium.Childhood trauma and mixed episodes are associated with poor response to lithium in bipolar disorders.Antipsychotic Drug-Induced Somnolence: Incidence, Mechanisms, and Management.The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies.Medical burden, body mass index and the outcome of psychosocial interventions for bipolar depression.Bipolar patients referred to specialized services of care: Not resistant but impaired by sub-syndromal symptoms. Results from the FACE-BD cohort.No evidence for metabolic syndrome and lipid profile differences in patients suffering from bipolar I disorder with and without suicide attempts.Plasma copeptin and metabolic dysfunction in individuals with bipolar disorder.Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.Pioglitazone adjunctive therapy for depressive episode of bipolar disorder: a randomized, double-blind, placebo-controlled trial.Bipolar disorder in women.Bipolar II disorder in patients with a current diagnosis of recurrent depression.Insulin resistance in bipolar disorder: relevance to routine clinical care.

P2860

Q26747785-B770B66E-A7F8-4A95-8E69-3CD3F57E40C3 Q33795131-CBD4BAF2-EAE9-4BAC-B248-A1DF141EB7A3 Q33835333-D412FDBA-4F6A-4B22-AFD5-FF1F9004CC2C Q33960389-374B43C5-DEA9-44D3-B9EF-D9A43880D256 Q34309209-0B7267A2-31DB-41EA-955E-BAFCDF984F4C Q34589883-CFB216B1-EAD5-4D46-B44B-2D6A5F348981 Q34983689-929828FC-0A74-4691-986F-A64581085232 Q35167517-19017661-8FD5-4EEC-BD7B-9CD52D76D24D Q35577365-0060EDB2-2856-4D61-BBEA-57E8BC9A04E2 Q35848001-C40D0E3C-9450-4888-92F5-4F2C78E3D271 Q35948836-5FE5F7F4-6B3D-4C12-9239-EB26EF16D30C Q36225626-DD38B55A-B363-4290-BCE5-C52461AE3BEE Q36269305-0756EBCB-3940-43DC-A8B4-F253B9573727 Q36553562-C5D6E7BA-B6F2-4B7B-9200-1AE7AE8A45B2 Q36721281-DC843DBF-45A9-4E40-ACB2-60B716978B4F Q36751327-596FC895-15F5-4C44-8787-74CE1352D511 Q36753982-FAEDD8AC-9579-4D36-AA81-370B3772B867 Q36834290-87C60F8E-C41A-449C-919E-3572A96E3714 Q37213547-B9DEC16B-9CBE-4880-A4AA-A9A190F04184 Q37244634-54A0F4CF-4402-4050-9E86-31C89A53B752 Q37351069-CB986931-A687-4579-9926-11E2E62F0CEB Q37514635-70A05F5E-E0C1-4628-9B4F-B2D95C516A37 Q37639334-48B4AEA6-C19C-4E7D-B819-355CC5F6EF53 Q37661867-A60C4512-DE1D-4911-B0F5-94E7171333E3 Q37671101-8536CACC-4257-4280-AD23-1AFE12748808 Q37863532-9A15BD4E-E79A-4832-B206-703197AAFD9D Q38012489-62C9806A-F799-4064-9B54-FC4362220C02 Q38023889-E2809942-E589-493E-A040-088AFA5B5AC0 Q38781602-203EB520-FC3A-41EB-BEE8-5469106AC6BB Q38884279-881EB58B-12E7-467A-AD1D-5893DD4B7691 Q39100917-E4B0C025-82AD-4479-8434-72FFD0E56E57 Q40294491-E1AD4377-C470-4DBC-AECE-28D7BDB8A380 Q40921191-68EFC76A-F8DC-4B08-AC90-EA2A4EADB8A5 Q40945173-7A897954-414B-408E-9962-BFBE93883363 Q42509069-D8A1C02E-8645-4E79-AF80-A02D03378FC8 Q44142664-A7B559D0-E97C-4470-A196-B09DACF3575A Q48128615-5A56F386-7557-4D73-8415-204B648CFF51 Q48191720-89B9B9D2-FE8B-47A7-BD25-173F2F31B20B Q48343394-2FAE9885-00B0-45D5-8FA6-24E196C5E99C Q50571436-44046D0C-3FC3-449A-95E1-AFF2AD5788E6

P2860

Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome

http://www.wikidata.org/entity/Q34034971

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Medical comorbidity in bipolar ...... c system and treatment outcome

@ast

Medical comorbidity in bipolar ...... c system and treatment outcome

@en

Medical comorbidity in bipolar ...... c system and treatment outcome

@nl

type

label

Medical comorbidity in bipolar ...... c system and treatment outcome

@ast

Medical comorbidity in bipolar ...... c system and treatment outcome

@en

Medical comorbidity in bipolar ...... c system and treatment outcome

@nl

prefLabel

Medical comorbidity in bipolar ...... c system and treatment outcome

@ast

Medical comorbidity in bipolar ...... c system and treatment outcome

@en

Medical comorbidity in bipolar ...... c system and treatment outcome

@nl

P1433

Q34034971-06874BD5-3A7C-41AE-AFFE-1CA07B245769

P1476

Q34034971-8257C7F2-4A73-4E77-B672-0C76A99CDA93

P2093

Q34034971-23536AC2-C5C7-4D3A-A133-3212C827FB69

Q34034971-4C1A5E1C-DF28-48FA-B53E-172D9414E809

Q34034971-5924E44D-0CEB-49EB-A1C4-4E954606CD95

Q34034971-68156AC9-FC9A-43FB-8D41-48A9E4FE777E

Q34034971-825A2F51-C3CE-457C-AFCB-FFC5D5100807

Q34034971-ECF705D0-D210-49E0-8ED5-2D3F7C9B1EE7

P2860

Q34034971-0E0F603D-CDA0-4A43-B416-D4E2FEA502A3

Q34034971-135EF2EB-29C1-4C78-9DE7-BD4B6D7039E7

Q34034971-152FE7E4-A6FD-4085-AC3B-2FF6CA529326

Q34034971-24806972-8156-4610-A320-4DF588ED61EE

Q34034971-2548A524-DDF7-4646-B758-71AEE40A1147

Q34034971-25C72F87-1DA1-4F10-A6AF-B443C5AC8C86

Q34034971-26A75A69-8DE8-41CC-9BF0-B2ECF76DD788

Q34034971-2993E94F-DC36-4547-8882-FAE6BA7C1C2C

Q34034971-3D42D163-B2A2-450B-9984-7CB230AA5C24

Q34034971-3D97639C-FDAE-48F6-B082-7E7D7B15961B

P304

Q34034971-A04C3343-588B-4F37-9B40-5F4F8CF2DB68

P31

Q34034971-8DF21863-215C-4A6B-A271-D9ED24AC408D

P356

Q34034971-64BA2C12-1177-4C62-8E72-A1D4E4049961

P433

Q34034971-2828458F-6CD0-455D-8F78-BFBD4517B275

P478

Q34034971-4D815E30-5AAD-4991-ACBF-B653C5BE2C30

P577

Q34034971-A79CD97B-D2B8-4004-9C9F-ABDDE06607E1

P5875

Q34034971-74E7FB54-ADD3-428A-BCBF-495E02A91901

P698

Q34034971-485F38F2-D322-453F-9142-1BB30FEA002F

P921

Q34034971-1786566F-6AE7-40D2-ABC5-87BE6262EB76

P932

Q34034971-36728B89-DF19-4533-8C17-1D632835760F

P356

J.1399-5618.2010.00823.X

P1433

Bipolar Disorders

P1476

Medical comorbidity in bipolar ...... c system and treatment outcome

@en

P2093

David E Kemp

http://www.w3.org/2001/XMLSchema#string

Joseph R Calabrese

http://www.w3.org/2001/XMLSchema#string

Keming Gao

http://www.w3.org/2001/XMLSchema#string

Philip K Chan

http://www.w3.org/2001/XMLSchema#string

Robert L Findling

http://www.w3.org/2001/XMLSchema#string

Stephen J Ganocy

http://www.w3.org/2001/XMLSchema#string

P2860

Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine

Deficits in dopamine clearance and locomotion in hypoinsulinemic rats unmask novel modulation of dopamine transporters by amphetamine

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

A new depression scale designed to be sensitive to change

A rating scale for mania: reliability, validity and sensitivity

Prevalence and clinical correlates of medical comorbidities in patients with bipolar I disorder: analysis of acute-phase data from a randomized controlled trial.

Should Depressive Syndromes Be Reclassified as "Metabolic Syndrome Type II"?

Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes.

P304

404-413

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1399-5618.2010.00823.X

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45269128

http://www.w3.org/2001/XMLSchema#string

P698

20636638

http://www.w3.org/2001/XMLSchema#string

P921

bipolar disorder

P932

2913710

http://www.w3.org/2001/XMLSchema#string